Top Markets
Coin of the day
Pear Therapeutics, Inc. Pear Therapeutics, Inc.

Pear Therapeutics, Inc.

PEAR
Rangering i aksjer #40500
Pear Therapeutics, Inc. is a commercial-phase medical company focused on... Pear Therapeutics, Inc. is a commercial-phase medical company focused on inventing and distributing digital therapeutics. Its current offerings include reSET, which addresses substance use disorders involving alcohol, cannabis, cocaine, and stimulants; reSET-O, prescribed alongside buprenorphine for opioid use disorder; and Somryst, a digital solution for chronic insomnia. Beyond these marketed therapies, the company maintains a robust development pipeline of 14 prospective products. These investigational treatments span various therapeutic areas, encompassing psychiatry, neurology, and non-central nervous system conditions like gastrointestinal, oncological, and cardiovascular disorders. Founded in 2013, Pear Therapeutics, Inc. is headquartered in Boston, Massachusetts.
Aksjekurs
$0.0048
Sist synkronisert: 2023-05-23
Markedsverdi
$132.48K
Endring (1 dag)
-20.00%
Endring (1 år)
0.00%
Land
US
Handel Pear Therapeutics, Inc. (PEAR)

Kategori

P/B-forhold for Pear Therapeutics, Inc. (PEAR)
P/B-forhold per 2026 TTM: 0
Ifølge Pear Therapeutics, Inc. sine siste finansielle rapporter og aksjekurs er selskapets nåværende P/B-forhold (TTM) 0. Ved slutten av 2026 hadde selskapet et P/B-forhold på 0.
P/B-historikk for Pear Therapeutics, Inc. fra 2026 til 2026
P/B-forhold ved hvert års slutt
År P/B-forhold Endre
Ikke nok data for de angitte datoene.
P/B-forhold for lignende selskaper eller konkurrenter